| Antibacterial properties of nanoparticles MJ Hajipour, KM Fromm, AA Ashkarran, DJ de Aberasturi, ... Trends in biotechnology 30 (10), 499-511, 2012 | 2927 | 2012 |
| Personalized protein coronas: a “key” factor at the nanobiointerface MJ Hajipour, S Laurent, A Aghaie, F Rezaee, M Mahmoudi Biomaterials science 2 (9), 1210-1221, 2014 | 286 | 2014 |
| Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide MJ Hajipour, J Raheb, O Akhavan, S Arjmand, O Mashinchian, ... Nanoscale 7 (19), 8978-8994, 2015 | 226 | 2015 |
| Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier S Krol, R Macrez, F Docagne, G Defer, S Laurent, M Rahman, ... Chemical reviews 113 (3), 1877-1903, 2013 | 212 | 2013 |
| Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges Z Bakhtiary, AA Saei, MJ Hajipour, M Raoufi, O Vermesh, M Mahmoudi Nanomedicine: Nanotechnology, Biology and Medicine 12 (2), 287-307, 2016 | 203 | 2016 |
| Advances in alzheimer’s diagnosis and therapy: The implications of nanotechnology MJ Hajipour, MR Santoso, F Rezaee, H Aghaverdi, M Mahmoudi, G Perry Trends in biotechnology 35 (10), 937-953, 2017 | 137 | 2017 |
| Protocol design for large–scale cross–sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016 S Djalalinia, M Modirian, A Sheidaei, M Yoosefi, H Zokaiee, B Damirchilu, ... Archives of Iranian medicine 20 (9), -, 2017 | 121 | 2017 |
| Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process S Mirsadeghi, R Dinarvand, MH Ghahremani, MR Hormozi-Nezhad, ... Nanoscale 7 (11), 5004-5013, 2015 | 120 | 2015 |
| Nanomedicine in healing chronic wounds: opportunities and challenges S Sharifi, MJ Hajipour, L Gould, M Mahmoudi Molecular pharmaceutics 18 (2), 550-575, 2020 | 107 | 2020 |
| Bypassing protein corona issue on active targeting: zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors R Safavi-Sohi, S Maghari, M Raoufi, SA Jalali, MJ Hajipour, ... ACS applied materials & interfaces 8 (35), 22808-22818, 2016 | 103 | 2016 |
| Nanotoxicology: advances and pitfalls in research methodology M Azhdarzadeh, AA Saei, S Sharifi, MJ Hajipour, AM Alkilany, ... Nanomedicine 10 (18), 2931-2952, 2015 | 93 | 2015 |
| Impact of gold nanoparticles on amyloid β-induced Alzheimer’s disease in a rat animal model: Involvement of STIM proteins M Sanati, F Khodagholi, S Aminyavari, F Ghasemi, M Gholami, ... ACS chemical neuroscience 10 (5), 2299-2309, 2019 | 85 | 2019 |
| Disease-specific protein corona sensor arrays may have disease detection capacity G Caracciolo, R Safavi-Sohi, R Malekzadeh, H Poustchi, M Vasighi, ... Nanoscale Horizons 4 (5), 1063-1076, 2019 | 78 | 2019 |
| Salt intake among Iranian population: the first national report on salt intake in Iran S Rezaei, Z Mahmoudi, A Sheidaei, Z Aryan, N Mahmoudi, K Gohari, ... Journal of hypertension 36 (12), 2380-2389, 2018 | 76 | 2018 |
| Disease-related metabolites affect protein–nanoparticle interactions M Tavakol, A Montazeri, R Naghdabadi, MJ Hajipour, S Zanganeh, ... Nanoscale 10 (15), 7108-7115, 2018 | 65 | 2018 |
| Probing fibronectin conformation on a protein corona layer around nanoparticles M Raoufi, MJ Hajipour, SMK Shahri, I Schoen, U Linn, M Mahmoudi Nanoscale 10 (3), 1228-1233, 2018 | 62 | 2018 |
| The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016 Z Aryan, N Mahmoudi, A Sheidaei, S Rezaei, Z Mahmoudi, K Gohari, ... Journal of clinical lipidology 12 (6), 1471-1481. e4, 2018 | 55 | 2018 |
| Mechanistic understanding of the interactions between nano-objects with different surface properties and α-synuclein H Mohammad-Beigi, A Hosseini, M Adeli, MR Ejtehadi, G Christiansen, ... ACS nano 13 (3), 3243-3256, 2019 | 52 | 2019 |
| Nanoscale technologies for prevention and treatment of heart failure: challenges and opportunities MJ Hajipour, M Mehrani, SH Abbasi, A Amin, SE Kassaian, JC Garbern, ... Chemical reviews 119 (21), 11352-11390, 2019 | 51 | 2019 |
| Zeolite nanoparticles inhibit Aβ–fibrinogen interaction and formation of a consequent abnormal structural clot H Derakhshankhah, MJ Hajipour, E Barzegari, A Lotfabadi, M Ferdousi, ... ACS applied materials & interfaces 8 (45), 30768-30779, 2016 | 51 | 2016 |
Morteza MahmoudiAssociate Professor, Michigan State UniversityAdresse e-mail validée de msu.edu
